Recombinant Ret Proto-Oncogene anticorps

N° du produit ABIN7828523

L’anticorps anti-Ret Proto-Oncogene Monoclonal Lapin est utilisé pour la détection de Ret Proto-Oncogene dans des échantillons de Humain et Souris. Il a été validé pour WB.

Aperçu rapide pour Recombinant Ret Proto-Oncogene anticorps (ABIN7828523)

Antigène: Ret Proto-Oncogene (RET)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp Ret Proto-Oncogene est non-conjugé

Application: Western Blotting (WB)

Clone: A548

Détail du produit anti-Ret Proto-Oncogene anticorps

Fonction: Recombinant Ret Monoclonal Antibody

Purification: Protein A purified

Immunogène: Recombinant human Ret fragment

Isotype: IgG, kappa

Information d'application

Indications d'application: WB 1:1000-1:5000

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

Date de péremption: 12 months

Détails sur Ret Proto-Oncogene

Antigène: Ret Proto-Oncogene (RET)

Autre désignation: Ret

Sujet: MTC,CDHF,CDHR,HSCR,Cadherin family member,RET-ELE,RET,CDHF12,CDHR16,HSCR1,MEN2A,MEN2B,MTC1,PTC,RET-ELE1,RET51,Cadherin family member 12,Proto-oncogene c-Ret,Proto-oncogene tyrosine-protein kinase receptor Ret,Proto-oncogene tyrosine-protein kinase receptor Ret,Cadherin family member 12,Proto-oncogene c-Ret,The Ret is a receptor tyrosine kinase that functions as a multicomponent receptor complex in conjunction with other membrane-bound, ligand-binding GDNF family receptors. Ligands that bind the Ret receptor include the glial cell line-derived neurotrophic factor (GDNF) and its congeners neurturin, persephin, and artemin. Research studies have shown that alterations in the corresponding RET gene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung's disease. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [

Poids moléculaire:

Calculated MW: 124 kDa

Observed MW: 175 kDa The actual band is not consistent with the expectation.

UniProt: P07949

Pathways: Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation